FDA
-
-
-
-
-
-
-
4D pharma Reports Full Year 2021 Financial Results, Operational Highlights, and Guidance for Key Milestones in 2022
-
-
-
-
-
-
-
4D pharma to Host Virtual KOL Event Discussing Asthma Treatment Landscape and Review of Positive Topline Results from Part A of Phase I/II Trial of MRx-4DP0004
-
-
-
-
-
-
-
4D pharma to Participate in Jefferies London Healthcare Conference
-
-
-
-
-
-
-
4D pharma Announces Passing of Chief Financial Officer John Beck
-
-
-
-
-
-
-
4D pharma Presents Additional Positive Results of Phase II Study of Blautix® for the Treatment of Irritable Bowel Syndrome
-
-
-
-
-
322,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

